ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1149

Cause-Specific Proportionate Mortality Trends in Idiopathic Inflammatory Myopathies

Ansaam Daoud1, Muhammad Shamim2, Loai Dweik3 and Haseeb Chaudhary4, 1Case Western Reserve University/University Hospitals, Akron, OH, 2University Hospitals/ Case Western Reserve University, Cuyahoga Falls, OH, 3Cleveland Clinic Akron General Internal Medicine, Akron, OH, 4Case Western Reserve University, Westlake, OH

Meeting: ACR Convergence 2024

Keywords: Mortality, Myopathies, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Idiopathic inflammatory myopathies (IIM) are associated with increased morbidity, mortality, and economic health burden compared to the general population despite advancements in overall disease management. However, the long-term trends in cause-specific mortality in IIM are lacking.

Methods: This retrospective cohort study utilized the Multiple Cause of Death files from the CDC’s National Center for Health Statistics to analyze IIM mortality data. The dataset includes US resident death certificates detailing demographics, a primary cause of death, and up to 20 contributory causes. We examined trends in proportionate cardiovascular mortality (PCM), respiratory mortality (PRM), infectious mortality (PIM), and neoplastic mortality (PNM), defined as the number of cause-specific deaths divided by all-cause mortality in IIM patients from 1999 to 2020. Linear regression and Chi-square tests were used for comparisons.

Results: During the study period, 11,785 deaths occurred in IIM patients. The mean age of patients with cardiovascular (CV) mortality was 73.5 + 14.07 years, with a total of 1661 deaths. PCM significantly decreased from 19.5% in 1999 to 11.3% in 2020 (p< 0.01), Figure 1(a). Ischemic heart disease (IHD) was the most common cause of CV mortality in IIM (44%). The mean age of death from respiratory causes was 69.0 + 12.31 years, with interstitial lung disease as the most common underlying cause (38%) from a total of 971 deaths. The PRM was 7.0% in 1999 and 10.3% in 2020 (p=0.20), Figure 1(b). A total of 358 deaths occurred from infectious causes, PIM showed a minor increase in trend from 3.0% to 3.3% (p< 0.01) Figure 1(c). With 1260 deaths from neoplasms, the PNM was 8.8% in 1999 to 9.2% in 2020(p=0.73), Figure 1(d). There was no gender-based difference in mortality from these causes. (Table 1)

Conclusion: The study provides nationwide insights into mortality trends from four major causes of death in IIM. CV mortality remained highest in IIM patients, although mortality trends have significantly improved over the last two decades. The impact on mortality from respiratory diseases and malignancies remained relatively constant, whereas death from infections was the lowest among the studied causes of mortality.

Supporting image 1

Figure 1. Cause-Specific Proportionate Mortality Trends in Idiopathic Inflammatory Myopathies from 1999 to 2020.

Supporting image 2

Table 1. All-Cause Mortality and Cause-Specific Mortality Demographics in Idiopathic Inflammatory Myopathies.

Supporting image 3

Table 2. Underlying Cause of Death of Cause-Specific Mortality in Idiopathic Inflammatory Myopathies.


Disclosures: A. Daoud: None; M. Shamim: None; L. Dweik: None; H. Chaudhary: None.

To cite this abstract in AMA style:

Daoud A, Shamim M, Dweik L, Chaudhary H. Cause-Specific Proportionate Mortality Trends in Idiopathic Inflammatory Myopathies [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cause-specific-proportionate-mortality-trends-in-idiopathic-inflammatory-myopathies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cause-specific-proportionate-mortality-trends-in-idiopathic-inflammatory-myopathies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology